Cited 3 times in
Does an Alternative Sunitinib Dosing Schedule Really Improve Survival Outcomes over a Conventional Dosing Schedule in Patients with Metastatic Renal Cell Carcinoma? An Updated Systematic Review and Meta-Analysis
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.